Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT03943355 Completed - Blunt Injuries Clinical Trials

Nonoperative Management Protocol in Patients With Blunt Splenic Injuries

Start date: January 1, 2014
Phase:
Study type: Observational

This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period in our institution.

NCT ID: NCT03942575 Completed - Breast Cancer Clinical Trials

The Risk of Postoperative Wound Complications Following the Use of Negative Pressure Wound Therapy in Patients Undergoing Mastectomy

ALEX
Start date: May 31, 2019
Phase: N/A
Study type: Interventional

To evaluate the risk of postoperative wound complications following the use of Avelle negative pressure wound therapy in patients undergoing mastectomy and flap fixation, which might serve as a basis for a randomized controlled trial

NCT ID: NCT03941600 Completed - Clinical trials for Spinal Cord Injuries

Feasibility of Exercise and Spinal Cord Injury

Start date: April 10, 2019
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the impact of a community-based exercise intervention (CBEI) for persons with spinal cord injury (PwSCI) on physiological and psychological well-being and identify barriers and facilitators to implementation.

NCT ID: NCT03941483 Completed - Clinical trials for Acute Kidney Injury (AKI)

Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery

Start date: November 1, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study was to evaluate the efficacy of postsurgery treatment with ASP1128 in subjects at risk for AKI following CABG and/or valve surgery. This study also investigated the safety and tolerability of postsurgery treatment with ASP1128, and pharmacokinetic characteristics of ASP1128 in subjects at risk for AKI following CABG and/or valve surgery.

NCT ID: NCT03940274 Completed - Spinal Cord Injury Clinical Trials

Walk-Training Program for Individuals With Chronic Spinal Cord Injury (SCI)

Start date: December 4, 2018
Phase: N/A
Study type: Interventional

Cardiovascular disease (CVD) is the common leading cause of death among people with spinal cord injury (SCI) and occurs at an early age in people with SCI as compared to able-bodied people. The findings are consistent in demonstrating a high prevalence of CVD among people with SCI. Lack of physical activity and/or prolonged sitting which is observed in people with SCI due to impaired/loss of motor function is associated with increased risk factors of CVD. By doing this study, researchers hope to learn the effects of walking training on cardiovascular health among people with chronic SCI.

NCT ID: NCT03938584 Completed - Surgery Clinical Trials

The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients

Start date: October 12, 2017
Phase: N/A
Study type: Interventional

The goal of this study is to perform a randomized clinical trial to assess the effects of vitamin C versus placebo on wound healing in mandibular fracture patients.

NCT ID: NCT03935321 Completed - Clinical trials for Spinal Cord Injury, Acute

NISCI - Nogo Inhibition in Spinal Cord Injury

NISCI
Start date: May 15, 2019
Phase: Phase 2
Study type: Interventional

The purpose of the NISCI trial is to test if an antibody therapy can improve movement and quality of life of tetraplegic patients. A previous trial showed this treatment is safe and well accepted. This is a placebo controlled, randomized, double blind, multicenter, multinational study to assess the safety, tolerability, feasibility and preliminary efficacy of early (within 4-28 days post injury) initiation of treatment with repeated bolus injections of NG-101 in cervical acute SCI patients. The study has 3 phases: screening/baseline Phase, treatment phase, and a follow-up phase. The study design will allow simultaneous enrolment of patients with complete or incomplete SCI. Enrolment and stratification of the patients is based and individualized prediction of upper limb outcomes. For further information please visit NISCI website: https://nisci-2020.eu

NCT ID: NCT03934983 Completed - Trauma Clinical Trials

Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge in Trauma

Start date: March 28, 2019
Phase:
Study type: Observational

This pilot study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QStat Cartridge in trauma patients.

NCT ID: NCT03934671 Completed - Hard-to-heal Wounds Clinical Trials

Evaluation of the Efficacy of an Antioxidant Dressing in Chronic Wound Healing

REOX
Start date: September 2, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to compare the effect of antioxidant dressing (active product) on chronic wound healing with the use of non-active wound dressing for healing in a moist environment (standard clinical practice) in patients with hard-to-heal wounds

NCT ID: NCT03934281 Completed - Amputation Clinical Trials

Study of the Value of Using a Honey Dressing Compared to the Use of a Standard Dressing on the Toe Amputation Wound in the Diabetic Patient

MELIDIAB
Start date: June 27, 2018
Phase: N/A
Study type: Interventional

Numerous scientific publications in France and internationally have described the healing, anti-bacterial, anti-oxidant, anti-inflammatory and immuno-modulating properties of honey. Honey is effective in the management of many infected or uninfected post-surgical wounds. This study focuses on post surgical wounds after toe amputation in diabetic patients. The main objective of this study is to compare the rate of epidermisation at six months for these wounds, between honey dressing and other dressing devices used according to the french Haute Autorité de Santé (HAS) recommendations